bibliographic entry 5795826 [be/5795826]
https://w3id.org/oc/corpus/be/5795826

is a
content
  • Kazda CM, Garhyan P, Kelly RP et al. A randomized, double‐blind, placebo‐controlled phase 2 study of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes. Diabetes Care 2015: dc151643. DOI: 10.2337/dc15-1643 [Epub ahead of print].
references